Novavax Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-247.73	440.3	-187.5	-545.06	-657.94	-1,744
Depreciation & Amortization	17.83	27.61	48.5	41.23	29.05	12.66
Stock-Based Compensation	32.33	36.02	48.15	85.36	130.3	183.63
Other Adjustments	-4.38	139.14	-44.89	81.35	443.8	136.79
Changes in Inventories	-2.15	-3.24	12.91	-74.46	-477.8	-8.87
Changes in Accounts Payable	-145.25	-322.57	-385.63	-378.81	913.4	600.33
Changes in Unearned Revenue	-69.74	-622.94	67.11	350.87	-1,046	1,326
Changes in Other Operating Activities	251.1	61.04	354.09	-274.44	249.17	-183.39
Operating Cash Flow	-36.9	-244.64	-87.26	-713.97	-415.94	322.95
Operating Cash Flow Growth	-	-	-	-	-	-
Capital Expenditures	-1.86	-5.56	-13.06	-53.77	-89.06	-54.5
Sale of Property, Plant & Equipment	59.4	19.65	192.64	-	-	-
Purchases of Intangible Assets	-	-0.83	-1.58	-5.04	-3.93	-2.99
Purchases of Investments	-626.36	-445.27	-825.59	-	-	-2.17
Proceeds from Sale of Investments	463.57	353.74	443.55	-	-	159.81
Investing Cash Flow	-109.51	-78.27	-204.04	-58.81	-92.99	100.15
Long-Term Debt Issued	46.41	42.61	-	-	175.25	-
Long-Term Debt Repaid	-	-	-	-325	-	-
Net Long-Term Debt Issued (Repaid)	46.41	42.61	-	-325	175.25	-
Issuance of Common Stock	-5.94	-4.8	264.58	360.4	248.59	589.62
Net Common Stock Issued (Repurchased)	-5.94	-4.8	264.58	360.4	248.59	589.62
Other Financing Activities	-8.36	-10.07	-3.99	-30.94	-98.85	-127.91
Financing Cash Flow	74.71	27.74	260.58	4.47	324.99	461.71
Foreign Exchange Rate Adjustments	-1.25	5.93	-7.8	3.27	4.52	-5.29
Net Cash Flow	-72.94	-289.24	-38.52	-765.04	-179.41	879.52
Free Cash Flow	-38.76	-250.2	-100.32	-767.74	-504.99	268.45
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	-9.37%	-22.27%	-14.71%	-78.05%	-25.48%	23.42%
Free Cash Flow Per Share	-0.24	-1.45	-0.66	-7.62	-6.46	3.61
Levered Free Cash Flow	-151.39	-382.74	-103.58	-1,259	-903.84	-51.97
Unlevered Free Cash Flow	-182.94	-410.95	-149.67	-953.77	-1,062	33.94

SEC Filings: 10-K · 10-Q